Nature Communications (Apr 2021)

Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1

  • A. Vuorela,
  • T. L. Freitag,
  • K. Leskinen,
  • H. Pessa,
  • T. Härkönen,
  • I. Stracenski,
  • T. Kirjavainen,
  • P. Olsen,
  • O. Saarenpää-Heikkilä,
  • J. Ilonen,
  • M. Knip,
  • A. Vaheri,
  • M. Partinen,
  • P. Saavalainen,
  • S. Meri,
  • O. Vaarala

DOI
https://doi.org/10.1038/s41467-021-22637-8
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 17

Abstract

Read online

Narcolepsy type 1 (NT1) is a severe sleep disorder with strong association to the HLA type DQB1*0602 and increased incidence among children vaccinated with the Influenza A vaccine Pandemrix. Here the authors show that these children develop T and B cell autoimmunity against protein-O-mannosyltransferase 1 via cross-reactivity.